Morgan Stanley analyst Stephen Grambling raised the firm’s price target on Caesars (CZR) to $32 from $25 and keeps an Equal Weight rating on the shares after various media outlets suggested that the company is weighing a takeover following interest from potential bidders, including Tillman Fertitta. Caesars’ struggle to drive consistently positive growth has weighed on the stock, but the reports of a potential takeover “could provide a floor,” improving the risk/reward, the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CZR:
